Matrix Sciences International

Matrix Sciences International

Matrix Sciences International provides laboratory testing, consulting, and data analytics services primarily to the food, beverage, and agricultural industries. The firm was formed through the 2018 acquisition by CI Capital Partners, a New York-based private equity firm that merged multiple legacy lab businesses under the Matrix Sciences brand per CI Capital's 2018 announcement. The company's founding year is not separately disclosed. The company's service offering spans microbiological testing, chemical analysis, shelf-life studies, and auditing for food safety programs—serving producers, processors, retailers, and government entities. Its geographic footprint includes multiple laboratory facilities across the United States, with a concentration in the Midwest per its public communications. The Atlanta, Dallas, and Minneapolis-St. Paul areas are among locations cited in its career postings. Matrix Sciences employs a team of scientists, microbiologists, and regulatory specialists, though exact headcount is not publicly available. In 2023, CI Capital Partners announced a partnership with institutional investor GCM Grosvenor to acquire a majority interest in Matrix Sciences, reflecting ongoing consolidation in the contract lab space per a market report. The firm operates a quality management system certified under ISO/IEC 17025, a standard that validates lab competence. A structural differentiator is Matrix Sciences' presence in a niche corner of the food supply chain where regulatory pressure and foodborne illness outbreaks drive steady demand for testing services. Rather than an asset manager deploying capital into passive holdings, Matrix Sciences is an operating business that generates cash flow from recurring testing contracts—a model less common among traditional investment firms.